European Commission Approves ADCETRIS® (brentuximab vedotin) for...
Business Wire IndiaTakeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Commission (EC) extended the current conditional marketing authori...